Leyla Shune, MD
Hematology & Oncology · Westwood, KSNPI 1700074614
Payments from drug & device makers
Across 255 payments — averaging $6900.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$646K
- Bristol Myers Squibb$514K
- Novartis$324K
- E.r. Squibb & Sons, L.L.C.$131K
- Pfizer$47K
- TG Therapeutics, Inc.$26K
- plus $72K from 13 others
Across 1 payment — averaging $553.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$554
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 162 | $646,372 |
| Bristol Myers Squibb | 2 | $513,786 |
| Novartis | 19 | $323,743 |
| E.r. Squibb & Sons, L.L.C. | 5 | $130,933 |
| Pfizer | 7 | $47,445 |
| TG Therapeutics, Inc. | 5 | $25,787 |
| AbbVie | 6 | $18,015 |
| Gilead | 14 | $15,024 |
| Incyte Corporation | 15 | $13,996 |
| Amgen | 4 | $9,939 |
| Legend Biotech USA Inc. | 2 | $4,925 |
| Janssen Scientific Affairs, LLC | 3 | $3,056 |
| Johnson & Johnson | 4 | $2,206 |
| AstraZeneca | 2 | $2,110 |
| National Marrow Donor Program | 1 | $2,063 |
| Genentech USA, Inc. | 1 | $143 |
| Genmab U.S., Inc. | 1 | $111 |
| Sanofi | 1 | $64 |
| ADC Therapeutics America, Inc. | 1 | $23 |
How this compares
$1,759,740 in reported general payments places this provider in the 85th percentile of 97 hematology & oncology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Westwood
- Priyanka SharmaWestwood$18.5M
- Anup Kumar Kasi Loknath KumarWestwood$15.3M
- Sunil AbhyankarWestwood$5M
- Prakash NeupaneWestwood$2.7M
- Gary DoolittleWestwood$2.6M
- Qamar KhanWestwood$1.3M
- Heather MaleWestwood$673K
- Muhammad Umair MushtaqWestwood$609K
- Haoran LiWestwood$472K
- Anthony SungWestwood$255K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.